Enzymatica AB: Completing the Nomination Committee's in Enzymatica AB proposal for AGM 2017 regarding election of auditor
05 April 2017 - 7:35PM
Press Release
Lund April 5, 2017
Completing the Nomination Committee's in
Enzymatica AB proposal for AGM 2017 regarding election of
auditor
The audit tender process is completed and the
Nomination Committee proposes election of auditor in accordance
with the following.
Proposal under item 12 in the
notice convening the annual general meeting: The Nomination
Committee proposes election of Deloitte AB as new auditor for a
mandate period of one year. In the event Deloitte AB is elected,
the accounting firm has informed that the authorized public
accountant Per-Arne Pettersson will be auditor in charge. The
Nomination Committee proposes that the auditors will be paid
according to approved invoice.
According to the decision of the AGM 2016, the
Nomination Committee shall consist of the Chairman and one
representative for each of the four largest shareholders at the end
of October every year. The Nomination Committee prior to the AGM
2017 comprises Håkan Roos, representing Abanico Invest AB,
Guðmundur Pálmason representing Protenus Holding Ltd., Águstá
Guðmundsdóttir representing Gadice ehf. and Björn Algkvist,
representing Fibonacci Asset Management AB.
For more information, please
contact:
Fredrik Lindberg, CEO Enzymatica AB
Tel: +46 708-86 53 70 | E-post: fredrik.lindberg@enzymatica.com
Enzymatica
Enzymatica is a life science company who develops and sells medical
device products against infectious-related diseases. Over a short
period the company has developed a unique oral spray for colds,
ColdZyme®, and launched it on eight markets. The product has become
one of the leading articles for colds in Swedish pharmacies.
Enzymatica's strategy is to continue growing by strengthening its
position in existing markets and to expand to more geographical
markets through well-established partners. The company is
headquartered in Lund, Sweden and is listed on Nasdaq First North.
For more information, please visit www.enzymatica.com.
Enzymaticas Certified Adviser is Erik Penser
Bank.
Enzymatica Press Release Nomination
Commmittee proposal of Auditor
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Enzymatica AB via Globenewswire
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More Enzymatica AB News Articles